Allweiss L. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combination with Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. PS-162.
Rechtstreekse vergelijking mRNA-vaccins bevestigt effectiviteit
jan 2022 | Vaccinatie, Virale infecties